Severe hyperglycemia in patients incorrectly using insulin pens at home. | AHRQ Patient Safety Network

Severe hyperglycemia in patients incorrectly using insulin pens at home. | AHRQ Patient Safety Network

• Press Release/Announcement
 
• Published October 2017

Severe hyperglycemia in patients incorrectly using insulin pens at home.

National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. October 12, 2017.

Care devices that enable patients to administer medicines at home can have unintended consequences. This alert raises awareness of hazards related to insulin pen misuse and offers recommendations to reduce risks, such as training patients to properly use pen needles and engaging community pharmacists in verifying that patients understand appropriate administration techniques.

Free full text (PDF)

Related Resources

CASES & COMMENTARIES

High-Risk Medications, High-Risk Transfers

Nancy Staggers, PhD, RN

LEGISLATION/REGULATION › ORGANIZATIONAL POLICY/GUIDELINES

ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults.

Horsham, PA: Institute for Safe Medication Practices; May 2017.

JOURNAL ARTICLE › REVIEW

The challenges of electronic health records and diabetes electronic prescribing: implications for safety net care for diverse populations.

Ratanawongsa N, Chan LLS, Fouts MM, Murphy EJ. J Diabetes Res. 2017;2017:8983237.

JOURNAL ARTICLE › STUDY

Medication errors associated with transition from insulin pens to insulin vials.

Trimble AN, Bishop B, Rampe N. Am J Health Syst Pharm. 2017;74:70-75.

JOURNAL ARTICLE › STUDY

Reduction of medication errors related to sliding scale insulin by the introduction of a standardized order sheet.

Harada S, Suzuki A, Nishida S, et al. J Eval Clin Pract. 2017;23:582-585.

View More